New Zealand markets closed

MRK May 2024 120.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
6.430.00 (0.00%)
As of 11:18AM EDT. Market open.
Full screen
Previous close6.43
Open6.43
Bid0.00
Ask0.00
Strike120.00
Expiry date2024-05-31
Day's range6.43 - 6.43
Contract rangeN/A
Volume3
Open interest6
  • Business Wire

    Merck to Acquire EyeBio

    RAHWAY, N.J. & NEW YORK, May 29, 2024--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.

  • Reuters

    Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

    Merck has said it's in the market for deals of up to around $15 billion as it plans ways to deal with a loss of revenue from its aging cancer immunotherapy Keytruda.

  • Investing.com

    Merck nears $1.3 bln takeover of Eyebiotech- WSJ

    Investing.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the rapidly growing eyecare market, the Wall Street Journal reported on Tuesday.